Emicizumab
Roche
['genentech']
#breaking: we presented new interim data at #ash22 from a phase iii study of our medicine in infants with severe #hemophilia a. learn more: 
Official Twitter for Genentech. See our community guidelines here: https://t.co/yas51FOJVm